Change Healthcare Cardiology Hemo Software — FDA record Z-2071-2025

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date May 22, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Change Healthcare Cardiology Hemo Software
Reason
Due to complaints, software update may cause software to unexpectedly shutdown.
Classification
Class II
Recalling firm
CHANGE HEALTHCARE CANADA COMPANY
Quantity
29 systems
Agency-reported status
Ongoing
Source record identifier
Z-2071-2025

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilitySoftware version 14.3.2/UDI: (01)17540262100051/ 15.0.1/UDI: (01)17540262100105

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, KY MO, MS, NE, NH, NJ, PA, TN, TX, WA and the countries of Australia, Canada, Germany, Great Britain, Ireland, Israel, New Zealand.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 9, 2025
Recall initiation date
May 22, 2025
Center classification date
Jul 2, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records